IDEXX beats ‘the Street’ on Q4 results, issues ’23 outlook

IDEXX Laboratories Inc. (NASDAQ) on Monday posted fourth-quarter earnings and revenues that beat estimates and issued a bullish initial outlook for 2023. 

The Westbroook-based provider of veterinary diagnostics, veterinary practice software and water testing reported earnings of $2.05 per share for the quarter that ended Dec. 31, beating the $1.92 per share consensus estimate of analysts polled by Zacks Investment Research. The figure compares to $1.89 per share for the third quarter of 2022. Read more

Related Posts

UMaine professor McGill receives top German research award

ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...

20 July 2023

Four Maine workforce programs could get $6.5M in fed funding

Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...

18 July 2023

Music as medicine: FDA approves stroke damage therapy from Portland startup

Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...

14 July 2023